Genetic Construction of Bacillus subtilis Recombinant Strain, Producing Protective Antigen of Anthrax Microbe

Anthrax is a serious infectious disease with high mortality. The epidemiological security depends on the vaccination of susceptible animals and population at risk. But many of the existing anthrax vaccine strains possess low levels of protective antigen production and high reactogenicity. One of the most promising trends in production of new generation of vaccines is the cloning of particular determinants of immunogenicity of anthrax microbe for the creation of highly effective producers of Bacillus anthracis protective antigen. The aim of the article is to present the results of the study on the construction of recombinant Bacillus subtilis strain, producing B.anthracis protective antigen, promising for use in chemical anthrax vaccines technology. The pHT43PA plasmid containing the gene pag, providing the synthesis of protective antigen of the anthrax microbe and functioning stably in the cells of the recombinant strain Amy21(pHT43РА) of B. subtilis, was constructed on the basis of the shuttle vector pHT43. It is found out during the research, that the microbial cells of the recombinant strain Amy21(pHT43РА) of B. subtilis provide the production of immunologically active protective antigen in quantities, not inferior than anthrax vaccine strains. These data, as well as safety and simplicity of В. subtilis make it possible to continue the research of this recombinant strain as a producer of anthrax protective antigen, promising for use in vaccines production.

1. Burgasov P.N., Cherkasskii B.L., Marchuk L.M. et al. Anthrax. Moscow Medicine, 1970. (in Russian).

2. Bondarev V.P., Filippov A.V., Darmov I.V. et al. Development of an immunoenzyme monoclonal test system for the detection of the protective antigen of Bacillus anthracis // Problems of Especially Dangerous Infections. 2007. T. 93. P. 66–69. (in Russian).

3. Onishchenko G.G., Vasil'ev N.T., Litusov N.V. et al. Anthrax: actual aspects of microbiology, epidemiology, clinic, diagnosis, treatment and prevention. Moscow, VUNMTs MZ RF, 1999. (in Russian).

4. Onishchenko G.G. Infectious diseases – the most important factor of biohazard // Epid. and Infect. Diseases. 2003. № 3. P. 4–16. (in Russian).

5. Kutirev V.V., Smirnova N.I. Genetic diagnostics and molecular typing of plague, cholera and anthrax // Molecular Genetics, Microbiology and Virology. 2003. № 1. P. 6–14. (in Russian).

6. Onishchenko G.G., Fedorov Iu.M., Tikhonov N.G. et al. Counteracting bioterrorism as a new problem in epidemiology // Epid. and Infect. Diseases. 2003. № 2, P. 4–6. (in Russian).

7. Inglesby T.V., Henderson D., Bartlett J.G. et al. Anthrax as a biological weapon. Updated recommendations for management // JAMA. 2002. V. 287. P. 2236–2252.

8. Pile J.C., Malone J.D., Eitzen E.M. et al. Anthrax as a potential biological warfare agent // Arch. int. Med. 1998. V. 158. P. 429–434.

9. Vasil'ev N.T., Pimenov E.V., Kozhukhov V.V. et al. Prospects for the creation of a new generation anthrax vaccine // Immunology. 1999. № 3. P. 5–8. (in Russian).

10. Mikesell P., Ivins В., Ristroph J. Evidence for plasmid-mediated toxin production in Bacillus anthracis // Infect. Immun. 1983. V. 39. P. 371–376.

11. Okinaka R., Cloud K., Hampton O. et al. Sequence and organization of pX01, the large Bacillus anthracis plasmid harboring the anthrax toxin genes // J. Bacteriol. 1999. V. 181. P. 6509–6515.

12. Klimpel K.R., Molloy S.S., Thomas G., Leppla S.H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin // Proc. Nat. Acad. Sci. USA. 1992. V. 89. P. 10277–10281.

13. Leppla S.H. The anthrax toxin complex // Sourcebook of Bacterial Protein Toxins / editors J.E. Alouf, J.H. Freer. Academic Press London. 1991. P. 277–302.

14. Vodkin M., Leppla S. Cloning of the protective antigen gene of Bacillus anthracis // Cell. 1983. V. 34. P. 693–697.

15. Alimov A.P., Pavlov V.M. The patent of the Russian Federation for invention No. 2110575. Recombinant plasmid DNA pro PF5, which determines the synthesis of the capsule antigen F1 of the plague and the protective antigen of the anthrax pathogen, and the method for constructing the recombinant plasmid DNA pro PF5. Bulletin No. 13 dated 10.05.1998. (in Russian).

16. Tedikov V.M., Dobritsa A.P. Cloning and expression of the determinant of the Bacillus anthracis protective antigen in cells of Escherichia coli, Bacillus subtilis and Bacillus anthracis // Molecular genetics, microbiology and virology. 1993. № 2. P. 13–16. (in Russian).

17. Chauhan V., Singh A., Waheed S. et al. Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli // Biochem. Biophys. Res. Commun. 2001. V. 283. P.308–315.

18. Coulson N.M., Fulop M., Titball R.W. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL3261, affords protection against anthrax spore challenge // Vaccine. 1994. V. 12. P. 1395–1401.

19. Zegers N, Kluter E., van Der Stap H. et al. Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: Towards the development of an oral vaccine against anthrax // J. Appl. Microbiol. 1999. Vol. 87. P. 309–314.

20. Pavlov V., Tedikov V., Mokrievich A. Cloning of pXOI and pag-gene of Bacillus anthracis in Francisella tularensis // International Workshop on Anthrax, 19-21 September 1995. Winchester, England. 1995. P. 108–109.

21. Baillie L. W. J., Moir A., Manchee R. The expression of the protective antigen Bacillus anthracis in Bacillus subtilis // J. Appl. Microbiol. 1998. V. 84. P. 741–746.

22. Cohen S., Mendelson L., Altboum Z. et al. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax // Infect. and Immun. 2000. V. 68. P. 4549– 4558.

23. Ivins В.E., Welkos S.L. Cloning and expression of the B.anthracis protective antigen in B.subtilis // Infect. and Immun. 1986. V. 54. P. 537–542.

24. Barnard J.P., Friedlander A.M. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen // Infect. and Immun. 1999. V. 67. P. 562–567.

25. Cloning DNA. Methods / Ed. Glover D. Translation from English. Moscow: Mir, 1988. (in Russian).

26. Experimental production schedule of production of anthrax vaccine combined liquid and dry for subcutaneous application № 862-99. Kirov, 1999. (in Russian).

27. Bacillus subtilis expression vectors product information and instructions, 2005.

28. Molecular clinical diagnosis. Methods/ Ed. Khyerrington S., Makgi J. Translation from English. Moscow: Mir, 1999. (in Russian).

29. Maniatis T., Frich E., Sambruk Dzh. Molecular cloning. Translation from English. Moscow: 1984. (in Russian).

30. MUK 4.1/4.2.588–96. Methods for monitoring medical immunobiological drugs administered to people. Moscow, 1996. (in Russian).